27 April 2020 Up to 100,000 Victorians will be tested for coronavirus over the next two weeks as part of a major testing blitz across the State, to better understand how the virus is spreading in the community…
23 April 2020 Australian researchers have made a world-first breakthrough that has the potential to monitor the changes in pH levels and other responses to therapy in stroke and cancer patients. Researchers from Monash University and the Baker…
27 April 2020 The Australian Commissioner of Taxation has extended the time to enrol for the initial JobKeeper periods, from 30 April 2020 until 31 May 2020. If you enrol by 31 May you will still be able to…
27 April 2020 From the Australian Government Treasury The Coronavirus Small and Medium Enterprises (SME) Guarantee Scheme will support up to $40 billion of lending to SMEs (including sole traders and not-for-profits). Under the Scheme, the Government will guarantee…
26 April 2020 The Australian Government today launches the new voluntary coronavirus app, COVIDSafe. The app is an important public health initiative that will help keep you, your family, and your community safe from further spread of coronavirus…
24 April 2020 The Morrison Government’s historic $130 billion JobKeeper payment will support millions of Australian jobs and help cushion the blow from the severe economic impact from the coronavirus. The $1,500 per fortnight JobKeeper payment is the…
23 April 2020 Ensuring Australian hospitals are able to respond rapidly in the event of increased patient demand during the COVID-19 health emergency is a national priority. Minister for Health, Greg Hunt, announced the Australian Government has funded…
22 April 2020 RMIT fashion and textiles experts have designed a new style of protective face mask for healthcare workers. The staff and student team has sewn 100 of the prototype masks as part of a Federal Government…
23 April 2020 Immutep Limited, a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announced that the last patient has been enrolled and safely dosed for the second cohort of the INSIGHT-004 Phase I clinical…
23 April 2020 PolyNovo is pleased to announce the first use of NovoSorb BTM in Canada. This case was initiated by one of Canada’s leading surgeons who is a key opinion leader in this field. PolyNovo has not…
21 April 2020 PolyNovo is pleased to share the summary of results for the CP-002 Feasibility Study to assess the safety and effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the treatment of severe skin burn injuries. This…
23 April 2020 Gilead Sciences, Inc. (Nasdaq: GILD), Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery and development of next-generation drug and engineered cell therapies…